1. Why am I using Wegovy®?

Wegovy® contains the active ingredient semaglutide. Wegovy® is used for weight loss and weight maintenance in addition to diet and physical activity in adults, and to reduce the risk of a heart disease related event if you are an adult with a history of heart disease and have a BMI ≥27 kg/m2. For more information, see Section 1. Why am I using Wegovy®? in the full CMI.

2. What should I know before I use Wegovy®?

Do not use if you have ever had an allergic reaction to semaglutide or any of the ingredients listed at the end of the CMI, or if you or a family member have had a certain type of thyroid cancer (MTC) or if you have an endocrine system condition called MEN 2.

Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use Wegovy®? in the full CMI.

3. What if I am taking other medicines?

Tell your doctor if you take other medicines. Some medicines may interfere with Wegovy®. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

4. How do I use Wegovy®?

• Take on an empty stomach, after a recommended fasting period of at least 8 hours. Swallow whole with a sip of water (up to 120 mL). Wait at least 30 minutes before having your first meal or drink of the day or taking other medicines.
• The starting dose is one 1.5 mg tablet once a day for one month.
• Your doctor will instruct you to gradually increase your dose every month until you reach the recommended dose of 25 mg once daily.

More instructions can be found in Section 4. How do I use Wegovy®? in the full CMI.

5. What should I know while using Wegovy®?

For more information, see Section 5. What should I know while using Wegovy®? in the full CMI.

6. Are there any side effects?

During treatment with Wegovy®, you may feel sick (nausea), or be sick (vomiting), or have diarrhoea. These side effects can cause dehydration (loss of fluids). It is important that you drink enough fluids to prevent dehydration.

Inflamed pancreas (acute pancreatitis) which could cause severe pain in the stomach and back which does not go away, allergic reaction (skin rashes over a large part of the body, shortness of breath, wheezing, swelling of the face, lips or tongue, fast pulse, sweating), loss of vision and bowel obstruction or severe constipation (including stool blockage) are very serious side effects for which you may need urgent medical attention. For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.

▼

Wegovy® tablet

Active ingredient(s): semaglutide

1.5 mg, 4 mg, 9 mg and 25 mg oral tablet

Consumer Medicine Information (CMI)

This leaflet provides important information about using Wegovy® tablet. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using Wegovy® tablet.

Keep this leaflet. You may need to read it again.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

Where to find information in this leaflet

1. Why am I using Wegovy®?

Wegovy® contains the active ingredient semaglutide. Wegovy® is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. Wegovy® works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight.

Wegovy® is used for weight loss and weight maintenance in addition to diet and physical activity in adults (18 years and older), who have

• a BMI of 30 kg/m² or greater (obesity), or
• a BMI of 27 kg/m² and less than 30 kg/m² (overweight) and weight-related health problems.

Wegovy® is used to reduce the risk of a heart disease related event in adults with a history heart disease who do not have Type 1 or Type 2 diabetes and have a BMI of 27 kg/m² or greater.

BMI (Body Mass Index) is a measure of your weight in relation to your height.

2. What should I know before I use Wegovy®?

Warnings

Do not use Wegovy® if:

• You or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2.
• You are allergic to semaglutide, or any of the ingredients listed at the end of this leaflet.
  Some of the symptoms of an allergic reaction may include:
  • rash, itching or hives on the skin
  • shortness of breath
  • wheezing or difficulty breathing
  • swelling of the face, lips, tongue or other parts of the body.
• Always check the ingredients to make sure you can use this medicine.
• Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
• It is after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering.
• It has expired or is damaged, return it to your pharmacist for disposal. The expiry date refers to the last day of that month.

The use of Wegovy® is not recommended if you:

• use other products for weight loss
• have type 1 diabetes
• have severe heart failure

There is little experience with Wegovy® in patients:

• of 85 years and older
• with an inflammatory bowel disease.

Please consult your doctor if one of the above applies to you.

Check with your doctor if you:

• have any other medical conditions
• have or have had depression, suicidal thoughts or any other major mental illness
• take any medicines for any other condition.

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

Check with your doctor if you are pregnant or intend to become pregnant.

This medicine should not be used during pregnancy, and for at least two months before a planned pregnancy because Wegovy® may harm your unborn child. Therefore, it is recommended to use contraception while using this medicine. If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped.

Talk to your doctor if you are breastfeeding or intend to breastfeed.

Do not use this medicine if you are breast-feeding. The medicine passes into breast milk, and it is not known how it affects your baby.

Food or liquid getting into lungs during anaesthesia

• Some patients taking medicines like Wegovy® have had problems with food or liquid from their stomach getting into their lungs while under general anaesthesia or deep sedation.
• Tell your healthcare professional that you are taking Wegovy® before you have a procedure that requires general anaesthesia or deep sedation.

Effects on the digestive system

During treatment with Wegovy®, you may feel sick (nausea), or be sick (vomiting), or have diarrhoea. These side effects can cause dehydration (loss of fluids) which may cause kidney problems. It is important that you drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. Tell your doctor straight away if you have nausea, vomiting, or diarrhea that does not go away.

Patients with delayed stomach emptying (gastroparesis)

If you have slow (delayed) stomach emptying (called gastroparesis), use of Wegovy® may lead to serious or severe gastrointestinal adverse events. Talk to your doctor before using Wegovy®.

Inflammation of the pancreas

If you have severe and on-going pain in the stomach area (see Section 6. Are there any side effects?) – see a doctor straight away as this could be a sign of an inflamed pancreas (acute pancreatitis).

Gallbladder problems

Wegovy® may cause gallbladder problems including gallstones. Some gallbladder problems need surgery. Call your healthcare provider if you have any of the following symptoms:

• pain in your upper stomach (abdomen)
• fever
• yellowing of skin or eyes (jaundice)
• clay-colored stools.

People with diabetes

Do not use Wegovy® as a substitute for insulin.

Low Blood Sugar (Hypoglycaemia)

Taking a sulfonylurea (such as gliclazide or glimepiride) or an insulin with Wegovy® might increase the risk of getting low blood sugar levels (hypoglycaemia). Please see section 6 for the warning signs of low blood sugar levels.

Your doctor may ask you to test your blood sugar levels. This will help your doctor decide if the dose of the sulfonylurea or insulin needs to be changed to reduce the risk of low blood sugar.

Diabetic eye disease (retinopathy)

Fast improvements in blood sugar control may lead to a temporary worsening of diabetic eye disease. If you have diabetic eye disease and experience eye problems while taking this medicine, talk to your doctor.

Sudden changes to your eyesight

If you notice a sudden loss of vision or rapidly worsening eyesight during treatment with this medicine, immediately contact your doctor for advice. This may be caused by a very rare side effect called non-arteritic anterior ischaemic optic neuropathy (NAION). Your doctor may refer you for an eye examination and you may have to stop treatment with this medicine. See additional information under Section 6. Are there any side effects?

Children and adolescents

This medicine is not recommended in children and adolescents under 18 years as the safety and efficacy in this age group have not been established.

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

Wegovy® may slow stomach emptying and can affect other medicines taken by mouth that need to pass through the stomach. Tell your doctor, pharmacist or nurse if you are taking:

• Warfarin or other similar medicines taken by mouth to reduce blood clotting (oral anti-coagulants). When you start treatment with e.g., warfarin or similar medicines, frequent blood testing to determine the ability of your blood to clot may be required.
• Other medicines taken by mouth that require regular monitoring or careful dose adjustments.

People with diabetes

Your doctor may adjust the dose of your diabetes medicines to prevent you from getting low blood sugar.

Do not use Wegovy® in combination with other medicines that contain GLP-1 receptor agonists (such as liraglutide, dulaglutide, exenatide or lixisenatide).

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect Wegovy®.

4. How do I use Wegovy®?

Your doctor or pharmacist will have given you advice on how to take your medicine. Carefully follow all the directions. They may differ from the information contained in this leaflet.

How much to take

• The starting dose is one 1.5 mg tablet once a day for one month.
• Your doctor will instruct you to gradually increase your dose every month until you reach the recommended dose of 25 mg once daily.
• Once you reach the recommended dose of 25 mg, do not increase this dose further.

Usually, you will be told to follow as below:

• Your doctor will assess your treatment on a regular basis. Wegovy® should always be taken as only one tablet per day. Taking more than one tablet a day should not be done to achieve the effect of a higher dose.

How to take Wegovy®

• Take your Wegovy® tablet on an empty stomach, after a recommended fasting period of at least 8 hours.
• Swallow your Wegovy® tablet whole with a sip of water (up to 120 mL). Do not split, crush or chew the tablet, as it is not known if it affects absorption of semaglutide.
• After taking your Wegovy® tablet wait at least 30 minutes before having your first meal or drink of the day or taking other oral medicines. Waiting less than 30 minutes lowers the absorption of semaglutide.

If you forget to use Wegovy®

If you forgot to take your Wegovy® tablet, the missed tablet should be skipped, and the next tablet should be taken the following day.

If you use too much Wegovy®

Talk to your doctor straight away. You may get side effects such as feeling sick (nausea), being sick (vomiting) or have diarrhoea, which may cause dehydration (loss of fluids).

If you think that you have used too much Wegovy®, you may need urgent medical attention.

You should immediately:

• phone the Poisons Information Centre
  (by calling 13 11 26 in Australia or 0800 764766 in New Zealand), or
• contact your doctor, or
• go to the Emergency Department at your nearest hospital.

You should do this even if there are no signs of discomfort or poisoning.

5. What should I know while using Wegovy®?

Things you should do

Call your doctor straight away if you:

• experience severe and on-going pain in the stomach area.
• experience changes in vision.

Tell any other doctors and pharmacists who treat you that you are taking this medicine.

• If you become pregnant while taking this medicine, tell
• your doctor immediately.

Things you should not do

• Do not stop using this medicine without talking to your doctor.
• Do not use this medicine if you think it has been frozen or exposed to excessive heat.
• Do not use this medicine to treat any other complaints unless your doctor tells you to.
• Do not give your medicine to anyone else, even if they have the same condition as you.
• Do not use this medicine after the expiry date which is stated on the blister label and carton. The expiry date refers to the last day of that month.

Driving or using machines

Be careful before you drive or use any machines or tools until you know how Wegovy® affects you.

Wegovy® is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking Wegovy® mainly during the first 4 months of treatment (see section 6). If you feel dizzy be extra careful while driving or using machines. If you need any further information, talk to your doctor, pharmacist or nurse.

People with diabetes

If you use this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate. Avoid driving or using machines if you get any signs of low blood sugar. See section 2 for information on increased risk of low blood sugar and section 6 for the warning signs of low blood sugar.

Looking after your medicine

• Store below 30°C.
• Store in original blister package to protect from moisture and light.

Keep it where young children cannot reach it.

Getting rid of any unwanted medicine

If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not use this medicine after the expiry date, which is stated on the blister and carton. The expiry date refers to the last day of that month.

6. Are there any side effects?

All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

Less serious side effects

Hypoglycaemia

The warning signs of low blood sugar may come on suddenly. They can include: cold sweat, cool pale skin, headache, fast heartbeat, feeling sick (nausea) or very hungry, changes in vision, feeling sleepy or weak, feeling nervous, anxious or confused, difficulty concentrating or shaking.

Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs.

Low blood sugar is more likely to happen if you also take a sulfonylurea or insulin. Your doctor may reduce your dose of these medicines before you start using this medicine.

Serious side effects

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Other side effects not listed here may occur in some people.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. If you are in New Zealand, you can report side effects at https://pophealth.my.site.com/carmreportnz/s/. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

This medicine is only available with a doctor's prescription.

What Wegovy® tablet contains

Wegovy® tablet contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially ‘sodium-free’.

Do not take this medicine if you are allergic to any of these ingredients.

What Wegovy® looks like

The 1.5 mg, 4 mg and 9 mg tablets are white to light yellow, round, debossed with '1.5', '4' or ‘9’ on one side and 'novo' on the other side.

The 25 mg tablet is white to light yellow, oval shaped, debossed with '25' on one side and 'novo' on the other side.

Wegovy® tablets are provided in blister cards which contain 1.5 mg, 4 mg, 9 mg and 25 mg semaglutide tablets.

Pack sizes of 1.5 mg tablets: 30 and 90 tablets.

Pack sizes of 4 mg tablets: 30 and 90 tablets.

Pack sizes of 9 mg tablets: 30 and 90 tablets.

Pack sizes of 25 mg tablets: 30 and 90 tablets.

Not all pack sizes may be marketed.

One Wegovy® tablet contains 1.5 mg, 4 mg, 9 mg or 25 mg of semaglutide.

Who distributes Wegovy®

Wegovy® is supplied in Australia by:

Novo Nordisk Pharmaceuticals Pty. Ltd.

Level 10

118 Mount Street

North Sydney NSW 2060

Wegovy® is supplied in New Zealand by:

Novo Nordisk Pharmaceuticals Ltd.

PO Box 51-268

Pakuranga

Auckland

New Zealand.

Wegovy®, is registered trademarks of Novo Nordisk A/S.

© 2026

Novo Nordisk A/S

Further information

For further information call Novo Nordisk Medical Information on 1800 668 626 (Australia) or 0800 733 737 (New Zealand).

www.novonordisk.com.au

www.novonordisk.co.nz

WegovyCare® is a free support program. To find out more go to:

wegovycare.com.au

The Patient Support Program is not authorised or approved by the Australian regulator of medicines, the TGA.

Always check the following websites to ensure you are reading the most recent version of the Wegovy® consumer medicine information:

www.novonordisk.com.au (AU)

https://www.ebs.tga.gov.au/ (AU)

www.novonordisk.co.nz (NZ)

https://www.medsafe.govt.nz/medicines/infosearch.asp (NZ)

This leaflet was prepared in October 2026